...
首页> 外文期刊>Journal of Applied Medical Sciences >Evaluation of albumin/globulin ratio as a diagnostic marker for relapsing ocular Beh?et’s disease
【24h】

Evaluation of albumin/globulin ratio as a diagnostic marker for relapsing ocular Beh?et’s disease

机译:评估白蛋白/球蛋白比作为复发性贝氏病的诊断指标

获取原文
           

摘要

Background: The aim of this study was to evaluate thealbumin/globulin (A/G) ratio as a diagnostic marker for relapsing ocular Beh?et’sdisease. Methods: This study was conducted using retrospective design.Patients of ocular Beh?et’s disease under infliximab infusion therapy wereregistered. The parameters for remission, i.e., total protein, albumin, serumprotein fraction, serum amyloid A (SAA), C reactive protein (CRP), erythrocytesedimentation rate (ESR), were monitored. The inflammatory proteins; α1-antitripsine, α1 acid glycoprotein, retinol binding protein,haptoglobin, ceruloplasmin, and α2 macroglobulin were measured during the pre- andpost- relapse phase in three patients. Results: Fourteen occurrences ofrelapse among 10 patients were confirmed during the study period. The A/G ratiodecreased to 0.10 ± 0.11 (mean ± SD), the increase in the mean percentage of α1 and α2 globulin fractions was statistically significant,and analysis of three patient samples showed an increase in α1 acid glycoprotein (p = 0.04) and a decrease inretinol binding protein (p = 0.04). Comparison of the A/G ratio with othermarkers, ESR, SAA, and CRP, between the pre- and post- relapse phase showedthat all four factors changed significantly.Conclusions: The A/G ratio appears to be a useful marker for relapsingocular Beh?et’s disease.
机译:背景:这项研究的目的是评估白蛋白/球蛋白(A / G)比作为复发性眼Beh?et病的诊断指标。方法:本研究采用回顾性设计进行。登记了英夫利昔单抗输注治疗的眼白塞氏病患者。监测缓解的参数,即总蛋白,白蛋白,血清蛋白组分,血清淀粉样蛋白A(SAA),C反应蛋白(CRP),红细胞沉降率(ESR)。炎性蛋白质;在三位患者的复发前后,分别测量了α1-抗tripsine,α1酸性糖蛋白,视黄醇结合蛋白,触珠蛋白,铜蓝蛋白和α2巨球蛋白。结果:在研究期间,确认10例患者中有14例复发。 A / G比降低至0.10±0.11(平均值±SD),α1和α2球蛋白分数的平均百分比增加具有统计学显着性,对三名患者样品的分析显示α1酸性糖蛋白增加(p = 0.04)和视黄醇结合蛋白减少(p = 0.04)。比较复发前和复发后阶段的A / G比率与其他标志物,ESR,SAA和CRP,发现所有四个因素均发生了显着变化。结论:A / G比率似乎是复发性Beh的有用标志物?等疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号